Thyroid Function TestsPipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Thyroid Function Tests (TFTs) are performed to evaluate the function of thyroid gland. TFTs are generally prescribed when a patient is suspected with abnormal level of thyroid hormones. Abnormal level of thyroid hormones in the body can cause either hyperthyroidism (high level of thyroid hormones) or hypothyroidism (low level of thyroid hormones). GlobalData’s Medical Devices sector report, “Thyroid Function Tests – Medical Devices Pipeline Product Landscape, 2021″ provides comprehensive information about the Thyroid Function Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Thyroid Function Tests report provides key information and data related to:
Extensive coverage of the Thyroid Function Tests under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Thyroid Function Tests pipeline products.
Review of Recent Developments in the segment / industry
The Thyroid Function Tests report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Thyroid Function Tests under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Thyroid Function Tests under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Thyroid Function Tests and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Thyroid Function Tests under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

AXO Science SAS
Canon Medical Systems Corp
GeneFluidics Inc
Immunodiagnostic Systems Holdings Ltd
Labsystems Diagnostics Oy
Mediomics, LLC
MedMira Inc
Novartis AG
Ohmx Corp
Ortho Clinical Diagnostics Holdings Plc
Paramedical Srl
Quidel Corp
redhot diagnostics AB
Roche Diagnostics International Ltd
Siemens Healthcare Diagnostics Inc
SpinChip Diagnostics AS
Sysmex Corp
Tecan Group Ltd
University Rovira i Virgili

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Thyroid Function Tests Overview 8

3 Products under Development 9

3.1 Thyroid Function Tests – Pipeline Products by Stage of Development 9

3.2 Thyroid Function Tests – Pipeline Products by Segment 10

3.3 Thyroid Function Tests – Pipeline Products by Territory 11

3.4 Thyroid Function Tests – Pipeline Products by Regulatory Path 12

3.5 Thyroid Function Tests – Pipeline Products by Estimated Approval Date 13

4 Thyroid Function Tests – Pipeline Products under Development by Companies 14

4.1 Thyroid Function Tests Companies – Pipeline Products by Stage of Development 14

4.2 Thyroid Function Tests – Pipeline Products by Stage of Development 15

5 Thyroid Function Tests Companies and Product Overview 16

5.1 AXO Science SAS Company Overview 16

5.1.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Canon Medical Systems Corp Company Overview 17

5.2.1 Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 GeneFluidics Inc Company Overview 18

5.3.1 GeneFluidics Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Immunodiagnostic Systems Holdings Ltd Company Overview 21

5.4.1 Immunodiagnostic Systems Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 Labsystems Diagnostics Oy Company Overview 22

5.5.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Mediomics, LLC Company Overview 23

5.6.1 Mediomics, LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 MedMira Inc Company Overview 25

5.7.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.8 Novartis AG Company Overview 26

5.8.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Ohmx Corp Company Overview 27

5.9.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Ortho Clinical Diagnostics Holdings Plc Company Overview 28

5.10.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 Paramedical Srl Company Overview 29

5.11.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 29

5.12 Quidel Corp Company Overview 30

5.12.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 30

5.13 redhot diagnostics AB Company Overview 31

5.13.1 redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 31

5.14 Roche Diagnostics International Ltd Company Overview 32

5.14.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.15 Siemens Healthcare Diagnostics Inc Company Overview 35

5.15.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 SpinChip Diagnostics AS Company Overview 37

5.16.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 37

5.17 Sysmex Corp Company Overview 38

5.17.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 38

5.18 Tecan Group Ltd Company Overview 40

5.18.1 Tecan Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.19 University Rovira i Virgili Company Overview 41

5.19.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 41

6 Thyroid Function Tests- Recent Developments 42

6.1 Oct 12, 2021: Veracyte to Release Third Quarter 2021 Financial Results on November 9 2021 42

6.2 Oct 12, 2021: Ortho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021 42

6.3 Sep 03, 2021: Ortho Clinical Diagnostics to Participate in September Investor Conferences 42

6.4 Sep 01, 2021: BioMerieux announce First-Half 2021 Results 42

6.5 Sep 01, 2021: Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology 43

6.6 Aug 04, 2021: Ortho Clinical Diagnostics Reports Second Quarter 2021 Results 43

6.7 Jul 29, 2021: Veracyte Announces Second Quarter 2021 Financial Results 45

6.8 Jul 26, 2021: PerkinElmer Announces Financial Results for the Second Quarter of 2021 46

6.9 Jul 23, 2021: Ortho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021 48

6.10 Jul 21, 2021: Novartis Announces Q2 2021 Financial Results 48

6.11 Jul 12, 2021: Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth 51

6.12 Jul 08, 2021: Veracyte to Release Second Quarter 2021 Financial Results on July 29, 2021 51

6.13 Jun 29, 2021: MedMira Reports Third Quarter Results FY2021 52

6.14 Jun 02, 2021: Veracyte to Present at Upcoming Investor Conferences 52

6.15 May 20, 2021: Ortho Clinical Diagnostics to Present at Upcoming Investor Conferences 52

6.16 May 10, 2021: Veracyte Announces CEO Succession Plan 53

6.17 May 10, 2021: Veracyte Announces First Quarter 2021 Financial Results 54

6.18 May 05, 2021: Ortho Clinical Diagnostics Reports First Quarter 2021 Results 55

6.19 May 04, 2021: PerkinElmer Announces Financial Results for the First Quarter of 2021 56

6.20 Apr 27, 2021: Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed 58

6.21 Apr 22, 2021: PerkinElmer supports PROXIDRUGS consortium aimed at advancing targeted protein degradation/PROTAC drugs 61

6.22 Apr 21, 2021: Ortho Clinical Diagnostics to Report First Quarter 2021 Results on May 5, 2021 62

6.23 Apr 15, 2021: Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results 62

6.24 Apr 02, 2021: Veracyte to Present at 20th Annual Needham Virtual Healthcare Conference 62

6.25 Mar 31, 2021: MedMira Reports Second Quarter Results FY2021 63

6.26 Mar 22, 2021: Novartis appoints Karen Hale as Chief Legal Officer 63

6.27 Mar 22, 2021: Veracyte Appoints Muna Bhanji to Its Board of Directors 64

6.28 Mar 18, 2021: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2020 Results 64

6.29 Mar 18, 2021: REPLACING: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2020 Results 65

6.30 Mar 04, 2021: Ortho Clinical Diagnostics to Report Fourth Quarter and Full Year 2020 Results on March 18, 2021 66

6.31 Feb 26, 2021: PerkinElmer to Present at Barclays Global Healthcare Conference 67

6.32 Feb 24, 2021: Thermo Fisher Scientific to Present at 41st Annual Cowen Healthcare Conference on March 3, 2021 67

6.33 Feb 16, 2021: PerkinElmer to Present at Cowen Health Care Conference 67

6.34 Feb 11, 2021: Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences 67

6.35 Feb 10, 2021: Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021 68

6.36 Feb 01, 2021: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2020 Results 68

6.37 Jan 06, 2021: Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference 70

6.38 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings 71

7 Appendix 72

7.1 Methodology 72

7.2 About GlobalData 75

7.3 Contact Us 75

Table

Thyroid Function Tests – Pipeline Products by Stage of Development 9

Thyroid Function Tests – Pipeline Products by Segment 10

Thyroid Function Tests – Pipeline Products by Territory 11

Thyroid Function Tests – Pipeline Products by Regulatory Path 12

Thyroid Function Tests – Pipeline Products by Estimated Approval Date 13

Thyroid Function Tests Companies – Pipeline Products by Stage of Development 14

Thyroid Function Tests – Pipeline Products by Stage of Development 15

AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 16

Multiplexed Detection Test – TSH – Product Status 16

Multiplexed Detection Test – TSH – Product Description 16

Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 17

Diagnostic Test – Thyroid Disorders – Product Status 17

Diagnostic Test – Thyroid Disorders – Product Description 17

GeneFluidics Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Free T3 Assay – Product Status 18

Free T3 Assay – Product Description 18

Free T4 Assay – Product Status 19

Free T4 Assay – Product Description 19

T3 Assay – Product Status 19

T3 Assay – Product Description 19

T4 Assay – Product Status 20

T4 Assay – Product Description 20

Immunodiagnostic Systems Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

IDS-iSYS Bioactive PTH (1-84) Kit – Product Status 21

IDS-iSYS Bioactive PTH (1-84) Kit – Product Description 21

Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 22

TSH Point Of Birth – Product Status 22

TSH Point Of Birth – Product Description 22

Mediomics, LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Immunoassay – TBAbs – Product Status 23

Immunoassay – TBAbs – Product Description 23

Immunoassay – TSAbs – Product Status 24

Immunoassay – TSAbs – Product Description 24

MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Reveal TSH Single Test – Product Status 25

Reveal TSH Single Test – Product Description 25

Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 26

Diagnostic Test – Thyroid Stimulating Hormone – Product Status 26

Diagnostic Test – Thyroid Stimulating Hormone – Product Description 26

Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Portable POC System – Thyroid Stimulating Hormone – Product Status 27

Portable POC System – Thyroid Stimulating Hormone – Product Description 27

Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 28

Diagnostic Assay – Thyroid Diseases – Product Status 28

Diagnostic Assay – Thyroid Diseases – Product Description 28

Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 29

PKL PPC 960 – TRAb – Product Status 29

PKL PPC 960 – TRAb – Product Description 29

Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 30

Thyretain TBI Reporter BioAssay – Product Status 30

Thyretain TBI Reporter BioAssay – Product Description 30

redhot diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 31

Diagnostic Kit – Thyroid Hormone – Product Status 31

Diagnostic Kit – Thyroid Hormone – Product Description 31

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

Cobas 8000 Analyzer Series With e 602 Module – Thyroglobulin Assay – Product Status 32

Cobas 8000 Analyzer Series With e 602 Module – Thyroglobulin Assay – Product Description 32

Cobas 8000 Analyzer Series With e 801 Module – Thyroglobulin Assay – Product Status 33

Cobas 8000 Analyzer Series With e 801 Module – Thyroglobulin Assay – Product Description 33

Thyroglobulin Assay – Product Status 33

Thyroglobulin Assay – Product Description 34

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Atellica IM Analyzer – Thyroglobulin (Tg) Assay – Product Status 35

Atellica IM Analyzer – Thyroglobulin (Tg) Assay – Product Description 35

Dimension Vista 1500 Intelligent Lab System – Intact PTH Assay – Product Status 36

Dimension Vista 1500 Intelligent Lab System – Intact PTH Assay – Product Description 36

Dimension Vista 500 Intelligent Lab System – Intact PTH Assay – Product Status 36

Dimension Vista 500 Intelligent Lab System – Intact PTH Assay – Product Description 36

SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 37

SpinChip – TSH Assay – Product Status 37

SpinChip – TSH Assay – Product Description 37

Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 38

Immunochemistry Test – Tg Ab – Product Status 38

Immunochemistry Test – Tg Ab – Product Description 38

Immunochemistry Test – TPO Ab – Product Status 39

Immunochemistry Test – TPO Ab – Product Description 39

Immunochemistry Test – TR Ab – Product Status 39

Immunochemistry Test – TR Ab – Product Description 39

Tecan Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Neonatal Screening Assay – Congenital Hypothyroidism – Product Status 40

Neonatal Screening Assay – Congenital Hypothyroidism – Product Description 40

University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 41

CD-Medics Test – Thyroiditis – Product Status 41

CD-Medics Test – Thyroiditis – Product Description 41

Figures

Thyroid Function Tests – Pipeline Products by Stage of Development 9

Thyroid Function Tests – Pipeline Products by Segment 10

Thyroid Function Tests – Pipeline Products by Territory 11

Thyroid Function Tests – Pipeline Products by Regulatory Path 12

Frequently asked questions

Thyroid Function TestsPipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Thyroid Function TestsPipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Thyroid Function TestsPipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Thyroid Function TestsPipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.